Jury Awards $4.7M In Mass. General Genetic Test Patent Trial
A Delaware federal jury on Friday found that European genetic testing company Qiagen willfully infringed a pair of patents owned by Massachusetts General Hospital and biotech company ArcherDX, awarding royalties and...To view the full article, register now.
Already a subscriber? Click here to view full article